Don’t miss the latest episode of The Bio Report podcast, where our CBO Hilary Eaton, PhD joined Daniel Levine for a wide-ranging conversation about the role of #GenerativeAI in drug development, our OpenCRISPR-1 molecule and why we made it open-source. 👉 https://lnkd.in/gkD4iAEt #AI #CRISPR #OpenCRISPR #ProteinDesign #Podcast
Profluent
Biotechnology Research
Berkeley, CA 4,773 followers
Decoding the language of life with AI
About us
Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Berkeley, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. To learn more about our mission to decode the language of life with AI, visit profluent.bio.
- Website
-
https://profluent.bio/
External link for Profluent
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Berkeley, CA
- Type
- Privately Held
- Founded
- 2022
- Specialties
- artificial intelligence, machine learning, biotech, and gene editing
Locations
-
Primary
Berkeley, CA, US
Employees at Profluent
Updates
-
Yesterday on BBC’s #AIDecoded, our CEO Ali Madani joined Christian Fraser and Priya Lakhani OBE to share how we’re using #AI to design entirely new #CRISPR medicines from scratch, and bring cures to people suffering from historically incurable genetic diseases. Check out the full segment here👇 https://lnkd.in/eMUFdUUv
AI gene editing tools have power to modify human DNA, say researchers | BBC News
https://www.youtube.com/
-
Join us next week at BIO, June 3-6 in San Diego, where our CBO Hilary Eaton, PhD will be giving a presentation on our AI-powered approach to #geneediting. We can't wait to connect with you to discuss how we're shaping the future of biotechnology. Find us on the One-on-One Partnering System. See you there! #BIO2024
-
Check out Ron Leuty’s piece in the San Francisco Business Times on how Profluent is driving a new chapter of drug discovery with generative AI 👇 https://lnkd.in/eUsU4F-e #AI #GenerativeAI #ProteinDesign #CRISPR
-
Don’t miss us this week at #PEGSBoston, where we’ll be detailing our success in building custom-designed, functional gene editors from scratch using #LLMs, plus teasing some antibody data. Poster on Thursday, talk on Friday. Details below 👇 #AI #GenerativeAI #ProteinDesign #CRISPR
-
Great to be at the American Society of Gene & Cell Therapy Annual Meeting last week, and to see so many people at the oral presentation on #OpenCRISPR given by our VP and Head of Gene Editing, Peter Cameron. It’s truly an exciting time in the field of #AI and gene editing 🚀 #ASGCT24
-
At this week’s American Society of Gene & Cell Therapy’s 27th Annual Meeting, Peter Cameron will be giving an oral presentation highlighting the potential of our AI-powered approach for custom-building gene editors. Details below 👇 #ASGCT2024 #AI #GenerativeAI #ProteinDesign #CRISPR
-
“It’s really just scratching the surface. It’s showing that it’s possible to design these complex systems with machine-learning models.” -CEO Ali Madani In Nature Portfolio, Ewen Callaway covers how we’re using protein language design to create highly performant CRISPR gene editors, and what this could mean for medical applications 👇 https://lnkd.in/eynnJJw6
‘ChatGPT for CRISPR’ creates new gene-editing tools
nature.com
-
#ICYMI, this week we published a research paper detailing our achievement of successfully editing the human genome with a gene editing system fully designed by #AI for the first time. We invite you to read our new blog where the paper’s co-first authors Jeffrey Ruffolo, Stephen Nayfach, Joseph Gallagher, and Aadyot Bhatnagar delve further into how we were able to leverage #LLMs to build our AI generated editor OpenCRISPR-1 and our decision to publicly release this gene editor to spur further research and innovation in the field. 👇 https://lnkd.in/gGs-Qgt7
-
Our CEO Ali Madani spoke with Cade Metz at The New York Times about our landmark achievement in editing the human genome with our AI-generated gene editor, OpenCRISPR-1. Check out the piece to learn more about our OpenCRISPR initiative and what its open-source release could mean for the future of CRISPR medicine development 👇 https://lnkd.in/dreNP-GE
Generative A.I. Arrives in the Gene Editing World of CRISPR
https://www.nytimes.com